PharmD Info

A forum for Indian Pharmacy Professionals

Share any Pharmaceutical related news with appropriate reference. Latest Pharmaceutical News, Indian Pharma News,
Forum rules: General rules are applicable for this forum- Find Here
  • User avatar
#2470
It’s a revolution when “US FDA” approved yesterday the FIRST gene-therapy medicine indicated for a disease other than cancer.

It’s “LUXTURNA” of “SPARK Therapeutics”.

There is a kind of vision-loss for people due to the defective gene namely “RPE65”.

“RPE65” gene produces a protein in our eye-cell which contributes to vision.

Vision-loss due to this “RPE65” gene is a hereditary disease and around 2000 people are being diagnosed in the USA every year.

“LUXTURNA” contains good “RPE65” genes and by administration of this to the eye can replace defective “RPE65” genes and thus can give vision.

Here, “trained”- virus carries the good “RPE65” genes to eyes.



Reference: https://www.fda.gov/NewsEvents/Newsroom ... 589467.htm
Similar Topics
Topics Statistics Last post
Therapeutics notes
by JahanviPatel    - In: Pharmacotherapeutics-I
0 Replies 
72 Views
by JahanviPatel
0 Replies 
93 Views
by Utkarsh2405
0 Replies 
370 Views
by smith4u
0 Replies 
480 Views
by Admin
0 Replies 
299 Views
by Admin

Refer pdf

Economic questions vise notes

Refer pdf and pharm d guru also

ICH GCP CDSCO

ICH GCP CDSCO guidelines

Various phases of CT

Various phases of CT in detail

PharmD Info - Highlights